ISSN: 1300-7777 E-ISSN: 1308-5263
Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases [Turk J Hematol]
Turk J Hematol. 2018; 35(4): 312-313 | DOI: 10.4274/tjh.2017.0464  

Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases

Rafet Eren, Elif Suyanı
University of Health Sciences, İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey

Keywords: Kronik lenfositik lösemi, Otoimmün hemolitik anemi, Bendamustin, Ritüksimab


Bendamustin ve Rituksimab Tedavisi ile Erken Direkt Antiglobülin Testi Negatifliği Elde Edilen İki Kronik Lenfositik Lösemi Olgusu

Rafet Eren, Elif Suyanı
University of Health Sciences, İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey

Anahtar Kelimeler: Chronic lymphocytic leukemia, Autoimmune hemolytic anemia, Bendamustine, Rituximab


Rafet Eren, Elif Suyanı. Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases. Turk J Hematol. 2018; 35(4): 312-313

Corresponding Author: Elif Suyanı, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2017) = 0.650